Differential Effect of Ticagrelor Versus Prasugrel Maintenence Dose on Endothelial Function of Peripheral Vessels in Patients With Coronary Artery Disease

Trial Profile

Differential Effect of Ticagrelor Versus Prasugrel Maintenence Dose on Endothelial Function of Peripheral Vessels in Patients With Coronary Artery Disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Jan 2017

At a glance

  • Drugs Ticagrelor (Primary) ; Prasugrel
  • Indications Acute coronary syndromes; Coronary artery disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 08 Jan 2017 Status changed from recruiting to completed.
    • 18 Aug 2015 Planned End Date changed from 1 Nov 2014 to 1 Dec 2015, as reported by ClinicalTrials.gov record.
    • 18 Aug 2015 Planned primary completion date changed from 1 Nov 2014 to 1 Dec 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top